Security key
P8696W104
SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (SVA)
CUSIP: P8696W104
Q4 2025 13F Holders as of 31 Dec 2025
- Security type / class
- Equity / Common Shares, par value US$0.001 per share
- Total 13F shares
- 6,270,749
- Total 13F value
- $40,853,096
- Share change
- +7,439
- SEC-reported price per share
- $6.47
- Number of holders
- 8
- Value change
- +$329,323
- Number of buys
- 2
- Shares outstanding
- 71,872,133
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2025
Institutions
8
Top holders
8
SVA full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2026
Previous quarter: Q3 2025
SINOVAC BIOTECH LTD SEC filings
SINOVAC BIOTECH LTD company facts
Broader feeds
Reporting periods
Holder history for CUSIP P8696W104
Recent filing periods:
Ownership snapshot
Top reported holders of SVA - SINOVAC BIOTECH LTD. - Common Shares, par value US$0.001 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
1Globe Capital LLC
Disclosed value leader
Vivo Capital IX, LLC
Comparable rows
14/14
Latest evidence
15 Dec 2025
13D/G
13F
Lead comparable stake: 32%
13D/G row: 1Globe Capital LLC
Showing 1-6 of 14 holder rows.
Quick read
1Globe Capital LLC leads the comparable SEC ownership view at 32%.
14 of 14 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens 1Globe Capital LLC's linked filing trail.
Comparable ownership
Top 5
1Globe Capital LLC
32%
SAIF Partners IV L.P.
15%
Yin Weidong
8.8%
Advantech Capital L.P.
8.1%
Vivo Capital IX, LLC
6.3%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 14 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| 1Globe Capital LLC |
13D/G
|
32%
|
—
18,515,315 shares
|
$0 | 07 Jul 2025 |
| SAIF Partners IV L.P. |
13D/G
|
15%
|
—
10,780,820 shares
|
$0 | 15 Dec 2025 |
| Yin Weidong |
13D/G
Weidong Yin
|
8.8%
|
—
6,359,500 shares
|
$0 | 10 Jul 2025 |
| Advantech Capital L.P. |
13D/G
|
8.1%
|
—
5,851,423 shares
|
$0 | 08 Jul 2025 |
| Vivo Capital IX, LLC |
13D/G
|
6.3%
|
$293,522,587
4,539,456 shares
|
$0 | 17 Mar 2025 |
| Vivo Capital VIII, LLC |
13D/G
Vivo Capital IX, LLC
|
6.3%
|
—
4,541,764 shares
|
$0 | 11 Jul 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
8
Shares
6,270,749
Rows available
8
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
8
Q4 2025 holders
8
Holder diff
0
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend